- World rank, all time
- #22,256 of 42,892
- Rank in United States
- #4,806 of 8,685
- Research works
- 144 ◆ 2% vs 2013–17
- Citations
- 3.3k 22.8 per fractional work
- Top-10% rate
- 11.9% record average 16.5%
- Open access
- 32% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.5×. Every wedge is a field page.
Who are the top researchers at Epic Sciences (United States)?
Ranked on the composite score, Ryan Dittamore lead among researchers whose main affiliation is Epic Sciences (United States).
- 1 Ryan Dittamore United States · #1,361,597 worldwide 25 citations · 26 works
Which keywords describe research at Epic Sciences (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Targeted Therapy, Drug Resistance, Cancer Stem Cells, Tumor Metastasis, Cancer Genomics, Mutational Signatures, Immunotherapy and Biomarkers.
- Tumor Microenvironment
- Androgen Receptor
- Gene Expression
- Prostate Cancer
- Clinical Trials
- Biomarkers
- Mutational Signatures
- Tumor Metastasis
- Drug Resistance
- Targeted Therapy
- Cancer Stem Cells
- Cancer Genomics
- Immunotherapy
- Chemotherapy
- Breast Cancer
- Cancer
- Metastasis
- Genomic Profiling
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 18 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 18 words, with their numbers
- Targeted Therapy6▲ 107×3 topics
- Drug Resistance5▲ 69×2 topics
- Cancer Stem Cells5▲ 445×1 topic
- Tumor Metastasis5▲ 350×1 topic
- Cancer Genomics5▲ 264×1 topic
- Mutational Signatures5▲ 264×1 topic
- Immunotherapy2▲ 12×3 topics
- Biomarkers2▲ 12×4 topics
- Chemotherapy2▲ 12×7 topics
- Clinical Trials2▲ 12×2 topics
- Breast Cancer2▲ 29×6 topics
- Prostate Cancer1▲ 44×2 topics
- Cancer1▲ 3.8×7 topics
- Gene Expression1▲ 8.8×3 topics
- Metastasis1▲ 16×2 topics
- Androgen Receptor1▲ 67×1 topic
- Genomic Profiling1▲ 47×1 topic
- Tumor Microenvironment1▲ 11×4 topics
Which research topics does Epic Sciences (United States) publish most on?
By volume in 2022–2025: Cancer Cells and Metastasis, Cancer Genomics and Diagnostics, Prostate Cancer Treatment and Research and HER2/EGFR in Cancer Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Cells and Metastasis Oncology 5 works
- 2 Cancer Genomics and Diagnostics Cancer Research 5 works
- 3 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
- 4 HER2/EGFR in Cancer Research Oncology 1 works
- 5 Single-cell and spatial transcriptomics Molecular Biology 1 works
- 6 Lung Cancer Research Studies Oncology 1 works
- 7 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 1 works
- 8 Cancer Diagnosis and Treatment Oncology 0 works
- 9 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
- 10 Cancer Immunotherapy and Biomarkers Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Epic Sciences (United States)'s research output changed?
Output in 2018–2022 was 2% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Diego
- University of California San Diego
- San Diego State University
- Scripps Research Institute
- University of San Diego
- University of California San Diego Medical Center
- General Atomics (United States)
- Scripps Health
- Naval Medical Center San Diego
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.